Published in Cephalalgia on December 01, 2000
Episodic dural stimulation in awake rats: a model for recurrent headache. Headache (2007) 1.34
Proinflammatory-activated trigeminal satellite cells promote neuronal sensitization: relevance for migraine pathology. Mol Pain (2009) 1.24
EP4 prostanoid receptor-mediated vasodilatation of human middle cerebral arteries. Br J Pharmacol (2004) 1.17
H2S and NO cooperatively regulate vascular tone by activating a neuroendocrine HNO-TRPA1-CGRP signalling pathway. Nat Commun (2014) 1.16
Calcitonin gene-related peptide enhances release of native brain-derived neurotrophic factor from trigeminal ganglion neurons. J Neurochem (2006) 1.14
Migraine: where and how does the pain originate? Exp Brain Res (2009) 1.06
Ionic mechanisms underlying inflammatory mediator-induced sensitization of dural afferents. J Neurosci (2010) 1.04
Electrophysiological properties of dural afferents in the absence and presence of inflammatory mediators. J Neurophysiol (2009) 1.04
Update on medication-overuse headache. Curr Pain Headache Rep (2011) 1.00
Stress and sleep duration predict headache severity in chronic headache sufferers. Pain (2012) 0.96
Calcitonin gene-related peptide: physiology and pathophysiology. Physiol Rev (2014) 0.96
Calcitonin gene-related peptide in blood: is it increased in the external jugular vein during migraine and cluster headache? A review. J Headache Pain (2009) 0.89
Headache-type adverse effects of NO donors: vasodilation and beyond. Br J Pharmacol (2010) 0.88
Modelling headache and migraine and its pharmacological manipulation. Br J Pharmacol (2014) 0.86
Distribution of artemin and GFRalpha3 labeled nerve fibers in the dura mater of rat: artemin and GFRalpha3 in the dura. Headache (2009) 0.85
Molecular mechanisms of migraine? J Neurol (2007) 0.85
Increased asymmetric dimethylarginine and nitric oxide levels in patients with migraine. J Headache Pain (2011) 0.85
Changes in calcitonin gene-related peptide (CGRP) receptor component and nitric oxide receptor (sGC) immunoreactivity in rat trigeminal ganglion following glyceroltrinitrate pretreatment. J Headache Pain (2013) 0.84
Relief of menstrual symptoms and migraine with a single-tablet formulation of sumatriptan and naproxen sodium. J Womens Health (Larchmt) (2014) 0.83
BGC20-1531, a novel, potent and selective prostanoid EP receptor antagonist: a putative new treatment for migraine headache. Br J Pharmacol (2009) 0.83
Plasma calcitonin gene-related peptide concentration is comparable to control group among migraineurs and tension type headache subjects during inter-ictal period. J Headache Pain (2009) 0.83
Meningeal blood flow is controlled by H2 S-NO crosstalk activating a HNO-TRPA1-CGRP signalling pathway. Br J Pharmacol (2015) 0.83
Acute migraine therapy: new drugs and new approaches. Curr Treat Options Neurol (2011) 0.82
Evaluation of ADMA-DDAH-NOS axis in specific brain areas following nitroglycerin administration: study in an animal model of migraine. J Headache Pain (2015) 0.81
Small internal jugular veins with restricted outflow are associated with severe multiple sclerosis: a sonographer-blinded, case-control ultrasound study. BMC Neurol (2013) 0.80
Reproducibility of forearm vasodilator response to intra-arterial infusion of calcitonin gene-related peptide assessed by venous occlusion plethysmography. Br J Clin Pharmacol (2005) 0.80
Reactive oxygen species induce procalcitonin expression in trigeminal ganglia glia. Headache (2014) 0.80
Update on future headache treatments. Neurol Sci (2013) 0.80
Sex differences in the inflammatory mediator-induced sensitization of dural afferents. J Neurophysiol (2011) 0.78
Capsaicin-induced vasodilatation in human nasal vasculature is mediated by modulation of cyclooxygenase-2 activity and abrogated by sulprostone. Naunyn Schmiedebergs Arch Pharmacol (2011) 0.78
The complex actions of sumatriptan on rat dural afferents. Cephalalgia (2012) 0.77
Sumatriptan does not change calcitonin gene-related peptide in the cephalic and extracephalic circulation in healthy volunteers. J Headache Pain (2009) 0.77
Sex-, Stress-, and Sympathetic Post-Ganglionic Neuron-Dependent Changes in the Expression of Pro- and Anti-Inflammatory Mediators in Rat Dural Immune Cells. Headache (2015) 0.76
Nasal decongestant and chronic headache: a case of naphazoline overuse headache? F1000Res (2013) 0.75
Tumor Necrosis Factor (TNF) -308G>A, Nitric Oxide Synthase 3 (NOS3) +894G>T Polymorphisms and Migraine Risk: A Meta-Analysis. PLoS One (2015) 0.75
Association between Chlamydia pneumoniae IgG antibodies and migraine. J Headache Pain (2009) 0.75
Efficacy of (S)-Lacosamide in preclinical models of cephalic pain. Pain Rep (2016) 0.75
Endometriosis and headache. Curr Pain Headache Rep (2011) 0.75
Nitric oxide release from trigeminal satellite glial cells is attenuated by glial modulators and glutamate. Int J Physiol Pathophysiol Pharmacol (2013) 0.75
[Primary headaches and the influence of inflammatory diseases of the CNS and their respective immunmodulatory therapy]. Schmerz (2007) 0.75
A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology (1994) 4.01
HCV-associated liver cancer without cirrhosis. Lancet (1995) 3.23
Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes. J Immunol (1982) 3.09
Antibodies to the surface of halothane-altered rabbit hepatocytes in patients with severe halothane-associated hepatitis. N Engl J Med (1980) 2.41
Clinical and virological profiles in patients with multiple hepatitis virus infections. Gastroenterology (1993) 2.29
Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications. Gut (2004) 2.22
Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection. Gastroenterology (1980) 2.04
Recognition of hepatitis B virus envelope proteins by liver-infiltrating T lymphocytes in chronic HBV infection. J Immunol (1989) 2.00
Vasoactive peptide levels in the plasma of young migraine patients with and without aura assessed both interictally and ictally. Cephalalgia (1995) 1.90
Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study. Cancer (1994) 1.81
Natural history and prognostic factors for chronic hepatitis type B. Gut (1991) 1.75
Selective killing of hepatitis B envelope antigen-specific B cells by class I-restricted, exogenous antigen-specific T lymphocytes. Nature (1990) 1.74
The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases. Aliment Pharmacol Ther (2011) 1.73
Hepatitis C virus infection in chronic hepatitis B virus carriers. J Infect Dis (1991) 1.69
Validity and reliability of the Italian version of the Chronic Liver Disease Questionnaire (CLDQ-I) for the assessment of health-related quality of life. Dig Liver Dis (2005) 1.69
HIV-1-specific B cell activation. A major constituent of spontaneous B cell activation during HIV-1 infection. J Immunol (1989) 1.66
Long-term follow-up of acute and chronic non-A, non-B post-transfusion hepatitis: evidence of progression to liver cirrhosis. Gut (1982) 1.60
Identification of an attachment site for human liver plasma membranes on hepatitis B virus particles. Virology (1989) 1.59
Energy metabolism of human LoVo colon carcinoma cells: correlation to drug resistance and influence of lonidamine. Clin Cancer Res (2000) 1.57
Incorrect echocardiographic diagnosis in patients with mechanical prosthetic valve dysfunction: correlation with surgical findings. Am J Med (2000) 1.55
Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminases. J Viral Hepat (2007) 1.54
Comparison of three algorithms of non-invasive markers of fibrosis in chronic hepatitis C. Aliment Pharmacol Ther (2011) 1.51
Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis. J Hepatol (1992) 1.50
Mediterranean Adequacy Index: correlation with 25-year mortality from coronary heart disease in the Seven Countries Study. Nutr Metab Cardiovasc Dis (2004) 1.49
GM1 ganglioside therapy in acute ischemic stroke. Italian Acute Stroke Study--Hemodilution + Drug. Stroke (1989) 1.48
Nitric oxide pathway, Ca2+, and serotonin content in platelets from patients suffering from chronic daily headache. Cephalalgia (1999) 1.48
Interferon antibodies in patients with chronic hepatitic C virus infection treated with recombinant interferon alpha-2 alpha. J Hepatol (1994) 1.43
Dispersal flight by Triatoma infestans in an arid area of Argentina. Med Vet Entomol (1988) 1.43
T-lymphocyte cytotoxicity to HBsAg-coated target cells in hepatitis b virus infection. Gut (1977) 1.42
Food habits in a southern Italian town (Nicotera) in 1960 and 1996: still a reference Italian Mediterranean diet? Diabetes Nutr Metab (2001) 1.41
ICHD 2nd Edition: Some considerations on the application of criteria for primary headache. Cephalalgia (2005) 1.41
Mees' lines due to cyclosporin. Br J Dermatol (1999) 1.39
Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B. Hepatology (1986) 1.38
[Coronary angioplasty in an Italian hospital without on-site cardiac surgery: the results and outlook]. G Ital Cardiol (1994) 1.38
Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors. Hepatology (1994) 1.37
Intracellular Mg++ concentration and electromyographical ischemic test in juvenile headache. Cephalalgia (1999) 1.37
Liver cell surface localization of hepatitis B antigen and of immunoglobulins in acute and chronic hepatitis and in liver cirrhosis. Clin Exp Immunol (1976) 1.35
Detection of a new antibody system reacting with Dane particles in hepatitis B virus infection. Br Med J (1978) 1.31
Effect of lonidamine on the energy metabolism of Ehrlich ascites tumor cells. Cancer Res (1981) 1.29
Ponto-bulbar palsy with deafness (Brown-Vialetto-Van Laere syndrome). J Neurol Sci (1981) 1.29
Fibrosis progression in initially mild chronic hepatitis C. J Viral Hepat (2006) 1.26
Differential distribution of hepatitis B core and E antigens in hepatocytes: analysis by monoclonal antibodies. Hepatology (1986) 1.26
Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis. Hepatology (1997) 1.24
Core antigen-specific immunoglobulin G bound to the liver cell membrane in chronic hepatitis B. Gastroenterology (1982) 1.24
Influence of hepatitis delta virus infection on progression to cirrhosis in chronic hepatitis type B. J Infect Dis (1987) 1.23
Long-term follow-up of anti-HBe-positive chronic active hepatitis B. Hepatology (1988) 1.23
Long-term follow-up of the hepatitis C HENCORE cohort: response to therapy and occurrence of liver-related complications. J Viral Hepat (2007) 1.21
Liver cell apoptosis in chronic hepatitis C correlates with histological but not biochemical activity or serum HCV-RNA levels. Hepatology (2000) 1.21
T lymphocyte sensitization to HBcAg and T cell-mediated unresponsiveness to HBsAg in hepatitis B virus-related chronic liver disease. Hepatology (1985) 1.20
Serum and liver HCV RNA levels in patients with chronic hepatitis C: correlation with clinical and histological features. Gut (1998) 1.20
The effect of interferon alfa and ribavirin combination therapy in naive patients with chronic hepatitis C. J Hepatol (1995) 1.19
Ten year incidence of HCV infection in northern Italy and frequency of spontaneous viral clearance. Gut (2003) 1.17
Cloning and expression of a novel hepatitis B virus-binding protein from HepG2 cells. J Biol Chem (2001) 1.17
Bioavailability and antioxidant activity of some food supplements in men and women using the D-Roms test as a marker of oxidative stress. J Nutr (2001) 1.17
Stroke and atrial fibrillation: is stroke prevention treatment appropriate beforehand? SAFE I Study Investigators. Heart (1999) 1.16
Definition of hepatitis B virus (HBV)-specific target antigens recognized by cytotoxic T cells in acute HBV infection. Clin Exp Immunol (1987) 1.16
Use of totally implantable central venous access ports for high-dose chemotherapy and peripheral blood stem cell transplantation: results of a monocentre series of 376 patients. Ann Oncol (2004) 1.16
Epidemiology of hepatitis C virus infection in seven European Union countries: a critical analysis of the literature. HENCORE Group. (Hepatitis C European Network for Co-operative Research. Eur J Gastroenterol Hepatol (2000) 1.16
Changes in hepatitis Be antigen/antibody system in children with chronic hepatitis B virus infection. J Pediatr (1983) 1.13
Patterns of antibodies to hepatitis C virus in patients with chronic non-A, non-B hepatitis and their relationship to viral replication and liver disease. Hepatology (1993) 1.13
[Bull semen ribonucleases. 1. Purification and physico-chemical properties of the major component]. Eur J Biochem (1972) 1.13
Psychiatric comorbidity and psychosocial stress in patients with tension-type headache from headache centers in Italy. The Italian Collaborative Group for the Study of Psychopathological Factors in Primary Headaches. Cephalalgia (1999) 1.13
Action of the antitumor and antispermatogenic agent lonidamine on electron transport in Ehrlich ascites tumor mitochondria. Arch Biochem Biophys (1983) 1.13
In vivo translational efficiency of different hepatitis C virus 5'-UTRs. FEBS Lett (1997) 1.12
High-level expression of hepatitis B viral antigens in fibrosing cholestatic hepatitis. Gastroenterology (1992) 1.12
Executive function in adolescents with Down Syndrome. J Intellect Disabil Res (2010) 1.12
Placebo-controlled comparison of effervescent acetylsalicylic acid, sumatriptan and ibuprofen in the treatment of migraine attacks. Cephalalgia (2004) 1.11
Retrospective analysis of the effect of interferon therapy on the clinical outcome of patients with viral cirrhosis. Cancer (1998) 1.10
Identification of a novel partner of RNA polymerase II subunit 11, Che-1, which interacts with and affects the growth suppression function of Rb. FASEB J (2000) 1.09
Histological evidence of hepatitis-B-virus infection with negative serology in children with acute leukaemia who develop chronic liver disease. Lancet (1982) 1.09
Hepatocellular carcinoma: comparison between liver transplantation, resective surgery, ethanol injection, and chemoembolization. Transpl Int (1998) 1.09
Cellular immunity to the hepatitis B virion in acute hepatitis type B. Clin Exp Immunol (1983) 1.08
An antibody which precipitates Dane particles in acute hepatitis type B: relation to receptor sites which bind polymerized human serum albumin on virus particles. Hepatology (1984) 1.08
Letter: HBAg on liver-cell surface in viral hepatitis. Lancet (1975) 1.07
Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C. Meta-analysis of individual patient data from European centers. J Hepatol (1997) 1.07
Hepatitis reactivation and liver failure in haemopoietic stem cell transplants for hepatitis B virus (HBV)/hepatitis C virus (HCV) positive recipients: a retrospective study by the Italian group for blood and marrow transplantation. Bone Marrow Transplant (2003) 1.06
Stroke related to carotid artery dissection in a young patient with Takayasu arteritis, systemic lupus erythematosus and antiphospholipid antibody syndrome. Cerebrovasc Dis (2002) 1.05
Anti-LSP antibodies in acute liver disease. Gut (1982) 1.05
Two PKR inhibitor HCV proteins correlate with early but not sustained response to interferon. Gastroenterology (2000) 1.05
Breakdown of double-stranded RNA by bull semen ribonuclease. Eur J Biochem (1969) 1.05
The preS1 domain of hepatitis B virus and IgA cross-react in their binding to the hepatocyte surface. J Gen Virol (1992) 1.03
CSF phosphorylated tau is a possible marker for discriminating Alzheimer's disease from dementia with Lewy bodies. Phospho-Tau International Study Group. Neurol Sci (2001) 1.03
Lonidamine, a selective inhibitor of aerobic glycolysis of murine tumor cells. J Natl Cancer Inst (1981) 1.03
Mild hyperhomocysteinemia is a risk-factor in all etiological subtypes of stroke. Neurol Sci (2004) 1.02
Prognostic value of the lymphocyte doubling time in chronic lymphocytic leukemia. Cancer (1987) 1.01
Non-organ specific autoantibodies in children with chronic hepatitis C. J Hepatol (1996) 1.01
Hepatic iron overload is common in chronic hepatitis B and is more severe in patients coinfected with hepatitis D virus. J Viral Hepat (2011) 1.01
Evidence for an association between the aetiology of cirrhosis and pattern of hepatocellular carcinoma development. Gut (2001) 1.01
Hepatitis C serotype and response to interferon therapy. N Engl J Med (1994) 1.00
Quantitation of adriamycin content by a sensitive immunochemical assay. Anticancer Res (1988) 1.00
Virus-associated receptors for polymerized human serum albumin in acute and in chronic hepatitis B virus infection. Gastroenterology (1983) 0.99
Hepatitis B virus precore/core variation and interferon therapy. Hepatology (1995) 0.99
An accessory open reading frame (orf-x) of jaagsiekte sheep retrovirus is conserved between different virus isolates. Virus Res (2000) 0.98